Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Seeing small but consistent progress each week boosted my confidence
Breast cancer In trials, 0.6% of Saxenda-treated patients developed breast cancer compared to 0.2% of placebo-treated patients
Risk of bias was assessed using an adapted Quality Assessment Tool for In Vitro Studies (QUIN) tool
Allergy history: Those with peptide allergies or multiple medication allergies face higher risk of allergic reactions to new peptides
Derecho de oposicin: Tiene derecho a oponerse al tratamiento basado en un inters legtimo
US$ 22.13
US$ 24.73
US$ 21.47
US$ 28.51
US$ 29.89
US$ 22.88
US$ 21.02
